CITRIREX Trademark

Trademark Overview


On Tuesday, December 12, 2017, a trademark application was filed for CITRIREX with the United States Patent and Trademark Office. The USPTO has given the CITRIREX trademark a serial number of 87718427. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 26, 2021. This trademark is owned by Sentar Pharmaceuticals. The CITRIREX trademark is filed in the Pharmaceutical Products category with the following description:

Medicinal preparations for improving hypoxia; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the treatment of pulmonary arterial hypertension, angina pectoris, and/or hypoxia; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treatment of the respiratory system; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical products for treating respiratory diseases; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, inducers of erections; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that...
citrirex

General Information


Serial Number87718427
Word MarkCITRIREX
Filing DateTuesday, December 12, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 26, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 24, 2018

Trademark Statements


Goods and ServicesMedicinal preparations for improving hypoxia; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the treatment of pulmonary arterial hypertension, angina pectoris, and/or hypoxia; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treatment of the respiratory system; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical products for treating respiratory diseases; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, inducers of erections; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of dissolvable tablets, orodispersible tablets, and/or sublingual tablets that facilitate the delivery of pharmaceutical preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 22, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSentar Pharmaceuticals
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92614

Party NameSentar Pharmaceuticals
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92614

Trademark Events


Event DateEvent Description
Monday, July 26, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 26, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 5, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 4, 2021EXTENSION 5 GRANTED
Tuesday, December 8, 2020EXTENSION 5 FILED
Monday, December 21, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 8, 2020TEAS EXTENSION RECEIVED
Wednesday, June 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 8, 2020EXTENSION 4 GRANTED
Monday, June 8, 2020EXTENSION 4 FILED
Monday, June 8, 2020TEAS EXTENSION RECEIVED
Thursday, October 17, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 15, 2019EXTENSION 3 GRANTED
Tuesday, October 15, 2019EXTENSION 3 FILED
Tuesday, October 15, 2019TEAS EXTENSION RECEIVED
Wednesday, May 22, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 24, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 22, 2019EXTENSION 2 GRANTED
Wednesday, May 22, 2019EXTENSION 2 FILED
Wednesday, May 22, 2019TEAS EXTENSION RECEIVED
Thursday, January 17, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 17, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 21, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 19, 2018EXTENSION 1 GRANTED
Wednesday, December 19, 2018EXTENSION 1 FILED
Wednesday, December 19, 2018TEAS EXTENSION RECEIVED
Tuesday, June 19, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 24, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 24, 2018PUBLISHED FOR OPPOSITION
Wednesday, April 4, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 22, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 22, 2018ASSIGNED TO EXAMINER
Friday, December 22, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, December 15, 2017NEW APPLICATION ENTERED IN TRAM